{"id":20064,"date":"2025-06-16T09:00:22","date_gmt":"2025-06-16T14:00:22","guid":{"rendered":"https:\/\/www.gnc.com\/learn\/?p=20064"},"modified":"2025-06-16T11:34:25","modified_gmt":"2025-06-16T16:34:25","slug":"gnc-glp1-nutrition-study","status":"publish","type":"post","link":"https:\/\/www.gnc.com\/learn\/newsroom\/gnc-glp1-nutrition-study.html","title":{"rendered":"GNC Leads Pioneering Study on Diet Trends Among GLP-1 Users Revealing Key Nutritional Gaps"},"content":{"rendered":"

While GLP-1s have been an effective weight loss tool, the first clinical GLP-1 nutrition study shows they can lead to low protein and essential nutrient intake <\/em><\/p>\n

Pittsburgh, PA, June 17, 2025<\/strong> \u2014GNC<\/a>, the leading global health and wellness retailer, continues its dedication to support individuals using GLP-1 agonists<\/a> in new groundbreaking scientific research revealing the first-ever real-world nutritional analysis of GLP-1 users. In an industry increasingly driven by trends, GNC is setting itself apart through research by doing what no one else has \u2014 conducting real-world research to understand the true nutritional needs of GLP-1 users. The study highlights critical evidence of everyday eating habits among GLP-1 users and the unintended nutritional deficiencies by decreasing food intake and changing dietary habits.<\/p>\n

“We set out last year to develop a product tailored to the unique needs of GLP-1 users,” said Dr. Brittany Johnson, PHD, RDN, Senior Manager, Scientific Affairs and Principal Investigator. “However, we quickly realized there simply wasn\u2019t enough evidence to inform a formula based on our scientific standards. That\u2019s why our team decided to start at the foundation and understand exactly what nutritional inadequacies exist in this population.”<\/p>\n

The novel research findings can help shape clinical practice guidance, supplement formulations, and education efforts to support the long-term success and safety of GLP-1 therapy, based on the population, not assumptions or speculation.<\/p>\n

The study conducted by senior researchers at GNC, “Investigating Nutrient Intake During Use of Glucagon-like Peptide-1 Receptor Agonist: A Cross-Sectional Study,” accepted for peer-reviewed publication in Frontiers<\/a>, involved 69 GLP-1 users over a three-day period, completing surveys and a detailed food log. Participant nutrient intake data was compared to the Dietary Reference Intakes (DRIs) using rigorous statistical analysis and demonstrated that participants did not meet vital nutrient intake through their diets and were significantly below recommended protein consumption.<\/p>\n

Key Findings of the Study:<\/strong><\/p>\n